Transitional Cell Cancer of the Renal Pelvis and Ureter

Showing 1 - 25 of 38

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Urothelial Carcinoma of the Renal Pelvis and Ureter, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial (ST-02)

Not yet recruiting
  • Urothelial Carcinoma of the Renal Pelvis and Ureter
  • Transitional Cell Cancer of the Renal Pelvis and Ureter
  • (no location specified)
Nov 7, 2023

Carcinoma, Transitional Cell Carcinoma, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial in Israel, United States

Withdrawn
  • Carcinoma
  • +2 more
  • UGN-101 instillations
  • Los Angeles, California
  • +4 more
May 5, 2020

Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Ureter Cancer Trial in United Kingdom (carboplatin,

Completed
  • Bladder Cancer
  • +3 more
  • Glasgow, Scotland, United Kingdom
  • +20 more
May 14, 2019

Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in United States (gemcitabine

Completed
  • Bladder Cancer
  • +2 more
  • Cedar Rapids, Iowa
  • +15 more
Dec 30, 2018

Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in United Kingdom (cisplatin,

Completed
  • Bladder Cancer
  • +2 more
  • Bristol, Avon, United Kingdom
  • +15 more
Oct 25, 2018

Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial in Charlotte, Greensboro, Winston-Salem

Completed
  • Bladder Cancer
  • Transitional Cell Cancer of the Renal Pelvis and Ureter
  • Charlotte, North Carolina
  • +2 more
Aug 8, 2018

Kidney Cancer or Cancer of Urothelium and in Healthy

Completed
  • Bladder Cancer
  • +3 more
  • immunologic technique
  • +2 more
  • Winston-Salem, North Carolina
    Wake Forest University Comprehensive Cancer Center
Jul 3, 2018

Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in Leeds (cisplatin, gemcitabine

Completed
  • Bladder Cancer
  • +2 more
  • Leeds, England, United Kingdom
    Leeds Cancer Centre at St. James's University Hospital
Feb 2, 2018

Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in United States (gemcitabine

Terminated
  • Bladder Cancer
  • +2 more
  • Mobile, Alabama
  • +91 more
Jul 8, 2016

Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in New York (sunitinib malate)

Completed
  • Bladder Cancer
  • +2 more
  • sunitinib malate
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Dec 17, 2015

Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial in Canada, United States (bortezomib)

Completed
  • Bladder Cancer
  • Transitional Cell Cancer of the Renal Pelvis and Ureter
  • Chicago, Illinois
  • +14 more
Jul 22, 2015

Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial in Copenhagen (cisplatin, gemcitabine HCl,

Completed
  • Bladder Cancer
  • Transitional Cell Cancer of the Renal Pelvis and Ureter
  • Copenhagen, Denmark
    Rigshospitalet - Copenhagen University Hospital
Jun 30, 2014

Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in Worldwide (fluorouracil)

Completed
  • Bladder Cancer
  • +2 more
  • Porto Alegre, Rio Grande do Sul, Brazil
  • +61 more
Dec 3, 2013

Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial in United States (filgrastim, docetaxel,

Unknown status
  • Bladder Cancer
  • Transitional Cell Cancer of the Renal Pelvis and Ureter
  • filgrastim
  • +2 more
  • La Jolla, California
  • +11 more
Dec 3, 2013

Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial in San Francisco, Tampa (chemo, tipifarnib)

Completed
  • Bladder Cancer
  • Transitional Cell Cancer of the Renal Pelvis and Ureter
  • San Francisco, California
  • +1 more
Dec 3, 2013

Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial in Canada, United States (oxaliplatin)

Completed
  • Bladder Cancer
  • Transitional Cell Cancer of the Renal Pelvis and Ureter
  • Chicago, Illinois
  • +13 more
Sep 4, 2013

Genes and Environment in Cancer in East Anglia, Trent, or West

Unknown status
  • Bladder Cancer
  • +8 more
  • DNA analysis
  • +3 more
  • Cambridge, England, United Kingdom
    University of Cambridge Cancer Research UK
Aug 23, 2013

Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in Milan (pazopanib HCl,

Completed
  • Bladder Cancer
  • +2 more
  • pazopanib hydrochloride
  • fludeoxyglucose F 18
  • Milan, Italy
    Fondazione Istituto Nazionale dei Tumori
Aug 9, 2013

Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in Barcelona, Madrid (drug,

Unknown status
  • Bladder Cancer
  • +2 more
  • sunitinib malate
  • +4 more
  • Barcelona, Spain
  • +3 more
Aug 6, 2013

Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial in New Orleans (biological, drug, procedure)

Completed
  • Bladder Cancer
  • Transitional Cell Cancer of the Renal Pelvis and Ureter
  • filgrastim
  • +5 more
  • New Orleans, Louisiana
    Tulane Cancer Center at Tulane University Hospital and Clinic
Jul 9, 2013

Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial in New York (filgrastim, carboplatin, doxorubicin

Completed
  • Bladder Cancer
  • Transitional Cell Cancer of the Renal Pelvis and Ureter
  • filgrastim
  • +4 more
  • New York, New York
  • +1 more
Jul 2, 2013

Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial in New York (filgrastim, cisplatin, doxorubicin

Completed
  • Bladder Cancer
  • Transitional Cell Cancer of the Renal Pelvis and Ureter
  • filgrastim
  • +5 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jul 2, 2013

Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial in New York (filgrastim, cisplatin, doxorubicin

Completed
  • Bladder Cancer
  • Transitional Cell Cancer of the Renal Pelvis and Ureter
  • filgrastim
  • +4 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 26, 2013